Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jun;90(6):1191.
doi: 10.4269/ajtmh.14-0040a.

Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in Panama

Begoña Monge-Maillo, Rogelio López-Vélez
Comment

Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in Panama

Begoña Monge-Maillo et al. Am J Trop Med Hyg. 2014 Jun.
No abstract available

PubMed Disclaimer

Comment in

  • In response.
    Grogl M, Sosa N, Kreishman-Deitrick M. Grogl M, et al. Am J Trop Med Hyg. 2014 Jun;90(6):1192. doi: 10.4269/ajtmh.14-0040b. Am J Trop Med Hyg. 2014. PMID: 24898982 Free PMC article. No abstract available.

Comment on

References

    1. Sosa N, Capitan Z, Nieto J, Nieto M, Calzada J, Paz H, Spandafora C, Kreisjman-Deitrick M, Kopydlowski K, Ullman D, McCarthy WF, Ranson J, Berman J, Scott C, Grogl M. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama. Am J Trop Med Hyg. 2013;89:557–563. - PMC - PubMed
    1. Krause G, Kroeger A. Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg. 1994;88:92–94. - PubMed
    1. Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for new world cutaneous leishmaniasis. Acta Trop. 2004;91:153–160. - PubMed
    1. Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, Bettaieb J, Gharbi A, Hamida NB, Boukthir A, Chlif S, Abdelhamid K, El Ahmadi Z, Louzir H, Mokni M, Morizot G, Buffet P, Smith PL, Kopydlowski KM, Kreishman-Deitrick M, Smith SK, Nielsen CJ, Ullman DR, Norwood JA, Thorne GD, McCarthy WF, Adams RC, Rice RM, Tang D, Berman J, Ransom J, Magill AJ, Grogl M. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med. 2013;368:524–532. - PubMed
    1. ClinicalTrials.gov . Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama. http://clinicaltrials.gov/ct2/show/NCT01790659 NCT01790659. Available at. Accessed January 16, 2014.

LinkOut - more resources